Skip to main content
DiagnosTear Technologies Inc. logo

DiagnosTear Technologies Inc. — Investor Relations & Filings

Ticker · DTR ISIN · CA25244H1055 LEI · 529900Y0T83PGBNF6A04 CSE Manufacturing
Filings indexed 73 across all filing types
Latest filing 2024-11-20 Regulatory Filings
Country CA Canada
Listing CSE DTR

About DiagnosTear Technologies Inc.

https://diagnostear.com/

DiagnosTear Technologies Inc. is an ophthalmic company specializing in advanced, disruptive diagnostic solutions for the management of eye diseases. The company focuses on point-of-care diagnosis of front-of-the-eye pathologies through the analysis of tear fluid composition. Its primary technology platform, TeaRx, facilitates the multi-parameter assessment of conditions such as Dry Eye Syndrome (DES) and Severe Meibomian Gland Dysfunction (MGD). Products like the TeaRx Red Eye diagnostic device are designed for commercial readiness and large-scale manufacturing. TeaRx is positioned as a critical tool for pre- and post-operative assessment in cataract and refractive surgeries, aligning with current ophthalmic guidelines.

Recent filings

Filing Released Lang Actions
Other material contract(s).pdf
Regulatory Filings
2024-11-20 English
Other material contract(s).pdf
Regulatory Filings
2024-11-20 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings
2024-11-20 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings
2024-11-20 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings
2024-11-20 English
Non-issuer's submission to jurisdiction and appointment of agent.pdf
Regulatory Filings
2024-11-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.